Avantor, Inc. Operating Income
Avantor, Inc. (AVTR) reported Operating Income of $99.50 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-04-29
- Avantor, Inc. operating income (loss) for the quarter ending 2026-03-31 was $99.50M, a 32.50% decline year-over-year.
- Avantor, Inc. operating income (loss) for the quarter ending 2025-12-31 was $126.40M, a 80.19% decline year-over-year.
- Avantor, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$648.80M, a 620.71% decline year-over-year.
- Avantor, Inc. operating income (loss) for the quarter ending 2025-06-30 was $128.80M, a 26.73% decline year-over-year.
- Avantor, Inc. operating income (loss) for fiscal 2025 was -$246.20M, a 122.70% decline from fiscal 2024.
- Avantor, Inc. operating income (loss) for fiscal 2024 was $1.08B, a 55.77% increase from fiscal 2023.
- Avantor, Inc. operating income (loss) for fiscal 2023 was $696.40M, a 38.38% decline from fiscal 2022.
- Avantor, Inc. operating income (loss) for fiscal 2022 was $1.13B, a 16.25% increase from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-03-31 | $99.50M 10-Q · filed 2026-04-29 | $225.90M derived: sum of 2 quarters · filed 2026-04-29 | -$422.90M derived: sum of 3 quarters · filed 2026-04-29 | -$294.10M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $126.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$522.40M derived: sum of 2 quarters · filed 2026-02-11 | -$393.60M derived: sum of 3 quarters · filed 2026-02-11 | -$246.20M 10-K · filed 2026-02-11 |
| 2025-09-30 | -$648.80M 10-Q · filed 2025-10-29 | -$520.00M derived: sum of 2 quarters · filed 2025-10-29 | -$372.60M 10-Q · filed 2025-10-29 | $265.50M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $128.80M 10-Q · filed 2025-08-01 | $276.20M 10-Q · filed 2025-08-01 | $914.30M derived: sum of 3 quarters · filed 2026-04-29 | $1.04B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $147.40M 10-Q · filed 2026-04-29 | $785.50M derived: sum of 2 quarters · filed 2026-04-29 | $910.10M derived: sum of 3 quarters · filed 2026-04-29 | $1.09B derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $638.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $762.70M derived: sum of 2 quarters · filed 2026-02-11 | $938.50M derived: sum of 3 quarters · filed 2026-02-11 | $1.08B 10-K · filed 2026-02-11 |
| 2024-09-30 | $124.60M 10-Q · filed 2025-10-29 | $300.40M derived: sum of 2 quarters · filed 2025-10-29 | $446.70M 10-Q · filed 2025-10-29 | $630.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $175.80M 10-Q · filed 2025-08-01 | $322.10M 10-Q · filed 2025-08-01 | $505.40M derived: sum of 3 quarters · filed 2026-02-11 | $715.60M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $146.30M 10-Q · filed 2025-04-25 | $329.60M derived: sum of 2 quarters · filed 2026-02-11 | $539.80M derived: sum of 3 quarters · filed 2026-02-11 | $611.50M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $183.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $393.50M derived: sum of 2 quarters · filed 2026-02-11 | $465.20M derived: sum of 3 quarters · filed 2026-02-11 | $696.40M 10-K · filed 2026-02-11 |
| 2023-09-30 | $210.20M 10-Q · filed 2024-10-25 | $281.90M derived: sum of 2 quarters · filed 2024-10-25 | $513.10M 10-Q · filed 2024-10-25 | $764.90M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-06-30 | $71.70M 10-Q · filed 2024-07-26 | $302.90M 10-Q · filed 2024-07-26 | $554.70M derived: sum of 3 quarters · filed 2025-02-07 | $830.50M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-03-31 | $231.20M 10-Q · filed 2024-04-26 | $483.00M derived: sum of 2 quarters · filed 2025-02-07 | $758.80M derived: sum of 3 quarters · filed 2025-02-07 | $1.05B derived: sum of 4 quarters · filed 2025-02-07 |
| 2022-12-31 | $251.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $527.60M derived: sum of 2 quarters · filed 2025-02-07 | $823.20M derived: sum of 3 quarters · filed 2025-02-07 | $1.13B 10-K · filed 2025-02-07 |
| 2022-09-30 | $275.80M 10-Q · filed 2023-10-27 | $571.40M derived: sum of 2 quarters · filed 2023-10-27 | $878.40M 10-Q · filed 2023-10-27 | $1.09B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $295.60M 10-Q · filed 2023-07-28 | $602.60M 10-Q · filed 2023-07-28 | $816.60M derived: sum of 3 quarters · filed 2024-02-14 | $1.05B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $307.00M 10-Q · filed 2023-04-28 | $521.00M derived: sum of 2 quarters · filed 2024-02-14 | $758.20M derived: sum of 3 quarters · filed 2024-02-14 | $1.01B derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $214.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $451.20M derived: sum of 2 quarters · filed 2024-02-14 | $705.90M derived: sum of 3 quarters · filed 2024-02-14 | $972.20M 10-K · filed 2024-02-14 |
| 2021-09-30 | $237.20M 10-Q · filed 2022-10-28 | $491.90M derived: sum of 2 quarters · filed 2022-10-28 | $758.20M 10-Q · filed 2022-10-28 | $962.80M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $254.70M 10-Q · filed 2022-07-29 | $521.00M 10-Q · filed 2022-07-29 | $725.60M derived: sum of 3 quarters · filed 2023-02-14 | $902.80M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $266.30M 10-Q · filed 2022-04-29 | $470.90M derived: sum of 2 quarters · filed 2023-02-14 | $648.10M derived: sum of 3 quarters · filed 2023-02-14 | $814.70M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $204.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $381.80M derived: sum of 2 quarters · filed 2023-02-14 | $548.40M derived: sum of 3 quarters · filed 2023-02-14 | $706.80M 10-K · filed 2023-02-14 |
| 2020-09-30 | $177.20M 10-Q · filed 2021-10-29 | $343.80M derived: sum of 2 quarters · filed 2021-10-29 | $502.20M 10-Q · filed 2021-10-29 | $654.10M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $166.60M 10-Q · filed 2021-07-30 | $325.00M 10-Q · filed 2021-07-30 | $476.90M derived: sum of 3 quarters · filed 2022-02-11 | $620.10M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $158.40M 10-Q · filed 2021-04-28 | $310.30M derived: sum of 2 quarters · filed 2022-02-11 | $453.50M derived: sum of 3 quarters · filed 2022-02-11 | $572.60M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $151.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $295.10M derived: sum of 2 quarters · filed 2022-02-11 | $414.20M derived: sum of 3 quarters · filed 2022-02-11 | $551.80M 10-K · filed 2022-02-11 |
| 2019-09-30 | $143.20M 10-Q · filed 2020-10-27 | $262.30M derived: sum of 2 quarters · filed 2020-10-27 | $399.90M 10-Q · filed 2020-10-27 | $499.20M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $119.10M 10-Q · filed 2020-07-29 | $256.70M 10-Q · filed 2020-07-29 | $356.00M derived: sum of 3 quarters · filed 2021-02-16 | $488.20M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $137.60M 10-Q · filed 2020-04-29 | $236.90M derived: sum of 2 quarters · filed 2021-02-16 | $369.10M derived: sum of 3 quarters · filed 2021-02-16 | $463.50M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $99.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $231.50M derived: sum of 2 quarters · filed 2021-02-16 | $325.90M derived: sum of 3 quarters · filed 2021-02-16 | $413.50M 10-K · filed 2021-02-16 |
| 2018-09-30 | $132.20M 10-Q · filed 2019-11-05 | $226.60M derived: sum of 2 quarters · filed 2019-11-05 | $314.20M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $94.40M 10-Q · filed 2019-08-06 | $182.00M 10-Q · filed 2019-08-06 | ||
| 2017-12-31 | -$210.40M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |